An interventional study of Deep brain stimulation in mesencephalic locomotor region and Implantation of a Deep brain stimulation system in Spinal Cord Injury, sponsored by University of Zurich. Recruiting at 1 site in Switzerland. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-05-29.
Sponsored by University of Zurich · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 24 studies in Spinal Cord Injuries by University of Zurich — 7 open to participants now, 7 under way, none of them phase 3. Spinal Cord Injuries · University of Zurich.
Among the 24 studies in Spinal Cord Injuries by University of Zurich, this one is the 14th largest by planned enrollment of the 14 interventional ones that give a count, is one of 3 that started in 2018, is one of 12 with no phase, and was the 12th registered.
2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.
Browse Spinal Cord Injuries studies →7 of the 24 studies in Spinal Cord Injuries by University of Zurich are open now, in 1 country. Recruiting first, the newest first:
University of Zurich · Sites in Switzerland
Ages 18–80 · Healthy volunteers
University of Zurich · Sites in Switzerland
Ages 18+ · Healthy volunteers
University of Zurich · Sites in Switzerland
Ages 18–80 · Healthy volunteers
University of Zurich · Sites in Switzerland
Ages 18+
University of Zurich · Sites in Switzerland
Ages 18–75 · Healthy volunteers
By country, each count listing its studies:
Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.
This study: 18 Years to 75 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
24 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 2
First in 2004; this study’s year is marked. 3 started in 2018.
This study's planned enrollment of 5 is below the median of 24 across 1,639 interventional studies indexed under Spinal Cord Injuries.
Median enrollment 64 across the 14 interventional studies, 204 across the 10 observational. Of the 17 that completed or were terminated, 1 (6%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of Zurich is the lead sponsor of 1,051 studies on the registry; 134 are open to participants now.
3 of the studies in Spinal Cord Injuries by University of Zurich that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT01571531University of ZurichEuropean Multicentre Study of Human Spinal Cord Injury | 2026-12 |
| NCT03053791University of ZurichDeep Brain Stimulation in Patients With Incomplete Spinal Cord Injury for Improvement of Gait | 2026-12 |
| NCT03772548University of ZurichCNS Changes Following SCI | 2027-06-30 |
Add all 3 to your calendar (.ics) → With an account.
Among the 24 studies in Spinal Cord Injuries by University of Zurich, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Spinal cord injuries are anatomically mostly incomplete, showing tissue bridges of the spinal cord at the injury site. Of the 60% functionally incomplete patients, about half face a life in the wheelchair. Besides conventional rehabilitation, no prominsing further treatment options exist. One of the most plastic systems involved in locomotion is the pontomedullary reticulospinal tract, which is the oldest locomotor command system existing in most vertebrates, including primates. Muscle activation patterns for limb movements are programmed in the spinal cord and have to be activated and coordinated through commands from the so called mesencephalic locomotor region (MLR). The MLR consists of nerve cells in the lower mesencephalic tegmentum sending uni- and bilateral signals through the medullary reticulospinal tracts. Classical physiological studies showed that electrical stimulation of the MLR induce locomotion. For the first time this approach was transferred and recently published in a model of induced incomplete spinal cord injury by the Schwab group. Rats severly impaired in motor hindlimb control with only 10-20% spared white matter, recovered with fully functional weight bearing locomotion under MLR deep brain stimulation (DBS). Even rats with only 2-10% spared white matter regained weight supporting stepping. DBS is a clinical standard treatment option in patients with movement disorders but does not relieve all symptoms. Therefore, small studies of MLR stimulations have been safely used in Parkinsonian patients showing freezing of gait and frequent falls with variable results. In a translational approach, we aim at performing a multidisciplinary phase one clinical trial with 5 patients and incomplete spinal cord injury. With the means of our established universitary setup for DBS treatments the operations will be performed unilaterally under local anaesthesia in the Division of Neurosurgery, USZ, with perioperative electrophysiological recordings, clinical assessments and gait analysis under test stimulation in the Spinal Cord Injury Center Balgrist.
After approval by the local ethics committee we will perform a phase I open-label trial to evaluate safety and preliminary efficacy of unilateral deep brain stimulation of the mesencephalic locomotor region in patients with incomplete spinal cord injury. Male or female subjects (18-75 year-old) with completed in-patient rehabilitation will be enrolled for screening evaluations at minimum 3 months post-injury. DBS operation will be performed at minimum 3 months post-injury. Primary endpoint will be improvement of locomotion as determined by the 6-Minute walking test.
Secondary endpoints will be electrophysiological/clinical and image based characterization of the mesencephalic locomotor region, questionnaire based/ professional assessments of quality of life, pain, micturition, sleep behavior, cognitive function and psychiatric evaluations (mood, anxiety, impulse control, delusional and affective disorders). The study population will consist of 5 subjects and the study period for each patient is 6 months postoperatively. Briefly, candidate subjects, able to stand with a walker or 2 crutches and with stable neurological condition will have to meet all of the inclusion and none of the exclusion criteria. Subjects will have preoperative examinations (e.g. MRI scans of the head and spine, neuropsychological, psychiatric and sleep status etc.) according to our standard protocols of DBS for movement disorders, especially Parkinson's disease, based on certification criteria of Highly-Specialized-Medicine DBS centers in Switzerland. Neurological assessments for spinal cord injury impairment as defined by study protocol will be performed at the University Hospital Balgrist.
The operation will be performed in the Division of Neurosurgeon by the neurosurgical PI of this study: awake subjects will have their heads fixed in a stereotactic ring with local anesthesia and high resolution head scans will be performed to define the stereotactic space for targeting through anatomical landmarks defined on individual MRI as described in the literature. In contrast to bilateral implantations in Parkinsonian patients, here, a single burr hole will be opened under local anesthesia on the contralateral side of the worse lower extremity of the subject. Microelectrode recordings of single-cells as well as local field potentials will be mapped starting 1 cm prior the MLR target. Four states will be analyzed: resting state, imagination of walking, passive and active lower limb movement. These recordings will help to further determine the places of stimulation as the next step of surgery. Here, slow increases of the stimulation amplitude with a constant frequency of e.g. 50Hz will be applied to determine activation of lower limb muscle activity with electroneuromyographic recordings and detection of possible amelioration of intended active movements. Since the subject is awake, possible side effects will be professionally monitored at each site of stimulation and amplitude. Next, the electrode for recording and stimulation will be exchanged with the standard 8-contact directional DBS electrode for Parkinson's disease patients (1.28 mm in diameter, 1.5mm length of each contact and 0.5 mm spacing in between). All subjects will receive an intraoperative head scan to verify correct placement and accuracy. If refinement is not necessary, the first operative procedure will be regarded as finished and the subject will be transferred to the intermediate care unit overnight to recover from surgery. The surgeon will decide, if the impulse generator will be implanted in the same surgery or delayed. Subjects will undergo regular assessments until discharge and further on in an outpatient setup around day 30 post-surgery, as well as 3 and 6 months afterwards. Rehabilitative postoperative treatment will be assisted by using the recently CE certificated and award winning FLOAT system ("Free Levitation for Overground Active Training") which allows robotic multidirectional relief of body weight and exact gait/posture analysis.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Relapsed: the illness came back after treatment had worked. Refractory: it did not respond to treatment, or stopped responding while still on it.
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Relapsed and refractory
Relapsed: the illness came back after treatment had worked. Refractory: it did not respond to treatment, or stopped responding while still on it.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Investigational drug or device
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraception
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Single-armed study. All patients will receive treatment.
Procedure: Deep brain stimulation in mesencephalic locomotor region · Device: Implantation of a Deep brain stimulation system
Implantation of Electrodes in the Mesencephalic Locomotor Region for improvement of Locomotion and Gait
Implantation of a Medtronic Percept PC Impulse Generator for chronic Stimulation of the selected target.
Change in 6 Minute Walk Test at baseline and 6 months post intervention
Standardized test. Patient is asked to walk for 6 minutes. Result is the distance covered
Time frame: preoperative, 6 months post intervention
Change in 10 Meter Walking Test towards baseline
Standardized test. Patient is asked to walk 10 meters as quickly as possible. Result is the speed (m/s)
Time frame: preoperative, early postop, before discharge, 1,3,6 months follow-up
Change in Timed Up and Go test (TUG) towards baseline
Standardized test. Patient is asked to stand up from a sitting into Standing Position and walk 3 m and return to seated position. Result ist time.
Time frame: preoperative, early postop, before discharge, 1,3,6 months follow-up
Kinematic assessment during overground and treadmill walking
Individuals are secured using the FLOAT.
Time frame: preoperative, early postop, before discharge, 1,3,6 months follow-up
Change in Spinal cord Independence measure (SCIM III) towards baseline
Standardized tool measuring the degree of independence of the subject. Result is score.
Time frame: preoperative, early postop, before discharge, 1,3,6 months follow-up
Change in Walking index for spinal cord injury (WISCI II) towards baseline
Standardized tool measuring the subject's ability to walk. Result is score.
Time frame: preoperative, early postop, before discharge, 1,3,6 months follow-up
Long-term monitoring of physical activity
Wearable and wireless sensors are mounted to the patient and wheelchair for constant monitoring of physical activity
Time frame: Continuously between discharge and 6 months follow-up
Electrophysiology
SSEPs, MEPs, DBS-EPs, LFPs, EMG
Time frame: Baseline and several time-points throughout the study.
Changes in Electroencephalography towards baseline
Evaluation for the occuracne of EEG abnormalities
Time frame: preoperative, intraoperative, early postop, 6 months follow-up
Change in Quality of life towards baseline
Standardized QOL tool (SF-36). Result is score.
Time frame: preoperative, 1,3,6 months follow-up
Change in lower urinary tract function towards baseline
Standardized tools QUALIVEEN, bladder diary, urodynamic assessments, renal and bladder ultrasound.
Time frame: preoperative, 6 months follow-up
Change in sexual functions towards baseline
Use of the standardized tools FSFI (Female Sexual Function Index), result is score respectively IIEF (International Index of Erectile Function), result is score
Time frame: preoperative, 1,3,6 months follow-up
Change in spasticity towards baseline
Use of the standardized tool MAS (Modified Ashword Scale). Result is score.
Time frame: preoperative, early postop, before discharge, 1,3,6 months follow-up
Changes in ASIA impairment scale (AIS)
Assment of neurological status of individual with SCI
Time frame: preoperative, early postop, before discharge, 1,3,6 months follow-up
Change in Upper limb Sensation, Strength and Prehension towards baseline
Standardized tool GRASSP
Time frame: preoperative, 6 months follow-up
Change in sleepiness towards baseline
Standardized tool Epworth Sleepiness Scale
Time frame: preoperative, 1,3,6 months follow-up
Change in Fatigue towards baseline
Standardized tool Fatigue Severity Scale
Time frame: preoperative, 1,3,6 months follow-up
Change in pain sensation towards baseline
Standardized tools EPAF and SCIPI
Time frame: preoperative, 1,3,6 months follow-up
Change in 6 Minute Walk Test at other timepoints towards baseline
Standardized test. Patient is asked to walk for 6 minutes. Result is the distance
Time frame: Screening, early postop, before discharge, 1,3 months follow-up
Plan to share: No
Started Mar 2018 (actual). Primary completion is estimated for Dec 2026, 105 months after the start.
Of 791 non-industry interventional studies with no phase under Spinal Cord Injuries, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 65. This study's planned 105 months is above that.
Counting every sponsor, half of 840 studies reached it within 36 months; a quarter within 17 and three quarters within 64.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.